Abstract:ABSTRACT Viruses are used as expression vectors for protein synthesis, immunology research, vaccines, and therapeutics. Advantages of poxvirus vectors include the accommodation of large amounts of heterologous DNA, the presence of a cytoplasmic site of transcription, and high expression levels. On the other hand, competition of approximately 200 viral genes with the target gene for expression and immune recognition may be disadvantageous. We describe a vaccinia virus (VACV) vector that uses an early promoter to express the bacteriophage T7 RNA polymerase; has the A23R intermediate transcription factor gene deleted, thereby restricting virus replication to complementing cells; and has a heterologous gene regulated by a T7 promoter. In noncomplementing cells, viral early gene expression and DNA replication occurred normally but synthesis of intermediate and late proteins was prevented. Nevertheless, the progeny viral DNA provided templates for abundant expression of heterologous genes regulated by a T7 promoter. Selective expression of the Escherichia coli lac repressor gene from an intermediate promoter reduced transcription of the heterologous gene specifically in complementing cells, where large amounts might adversely impact VACV replication. Expression of heterologous proteins mediated by the A23R deletion vector equaled that of a replicating VACV, was higher than that of a nonreplicating modified vaccinia virus Ankara (MVA) vector used for candidate vaccines in vitro and in vivo , and was similarly immunogenic in mice. Unlike the MVA vector, the A23R deletion vector still expresses numerous early genes that can restrict immunogenicity as demonstrated here by the failure of the prototype vector to induce interferon alpha. By deleting immunomodulatory genes, we anticipate further improvements in the system. IMPORTANCE Vaccines provide an efficient and effective way of preventing infectious diseases. Nevertheless, new and better vaccines are needed. Vaccinia virus, which was used successfully as a live vaccine to eradicate smallpox, has been further attenuated and adapted as a recombinant vector for immunization against other pathogens. However, since the initial description of this vector system, only incremental improvements largely related to safety have been implemented. Here we described novel modifications of the platform that increased expression of the heterologous target gene and decreased expression of endogenous vaccinia virus genes while providing safety by preventing replication of the candidate vaccine except in complementing cells used for vector propagation.

Construction of pVAX-1-based linear covalently closed vector with improved transgene expression

Design of a Retrovirus-Derived Vector for Expression and Transduction of Exogenous Genes in Mammalian Cells

Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells.

Construction of novel conditional transgenic vectors for molecular therapy based on the Tet-On system and flanked with insulators in a single plasmid

An Enhanced Retroviral Vector for Efficient Genetic Manipulation and Selection in Mammalian Cells

A novel application of baculovirus in mammalian gene therapy]

Construction and Identification of Eukaryotic Expression Vector for HCMV IE1-GFP Fusion Protein

Novel Enhanced Mammalian Cell Transient Expression Vector via Promoter Combination

Generation of a Stable Mammalian Cell Line for Simultaneous Expression of Multiple Genes by Using 2A Peptide-Based Lentiviral Vector

Regulatory elements in vectors containing the ctEF-1α first intron and double enhancers for an efficient recombinant protein expression system

Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins

Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors

Construction and Characterization of a High-Capacity Replication-Competent Murine Cytomegalovirus Vector for Gene Delivery

Design and construction of a versatile system for the expression of foreign genes in plants

Lentiviral Delivery of Proteins for Genome Engineering

Construction of Transferring Vector of Marek's Disease Virus Expressing GFP Gene and Its Primary Application

Advances on Highly Efficient Expression System of Mammalian Cells

An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression.

Synthetic biology approach to developing all-in-one baculovirus vector using mammalian introns and miRNA binding sites

Phage N15-Based Vectors for Gene Cloning and Expression in Bacteria and Mammalian Cells

A Single-Ltr HIV-1 Vector Optimized for Functional Genomics Applications